BACKGROUND: We set out to determine the effects of transfusing stored red blood cells (RBCs) on the levels of procoagulant microparticles (MPs) in the blood of trauma patients. METHODS: Blood was drawn and processed to platelet poor plasma for MP analysis for 409 injured patients seen in the trauma bay from February 2011 to January 2013. Blood from 27 noninjured volunteers was also analyzed. Quantification of total procoagulant MP (per microliter plasma) using a direct plasma analysis via flow cytometry was performed. Demographic data, Injury Severity Score (ISS), overall mortality, and units of transfused packed RBCs were collected. Data are presented as median (interquartile range [IQR]). Transfusion groups were assessed using t test or Wilcoxon rank-sum test as appropriate. The α level was set as 0.05 for statistical significance. RESULTS: Median ISS was 12 (IQR, 5-19), 12% were transfused, median age was 48 years (IQR, 29-62 years), 68% were male, and overall mortality was 3%. Median units transfused were 3 (IQR, 2-5). The median number of all procoagulant MP was greater in trauma patients (median 758; IQR, 405-1,627) when compared with our control subjects (median, 232; IQR, 125-372; p < 0.0001). This difference remained significant after adjusting for age and sex (p < 0.0001). In 39 patients who had MP levels measured before transfusion with RBC, the procoagulant MP levels did not change after transfusion (p = 0.07). Patients transfused with RBCs that were 14 days or older did not have increased procoagulant MP levels when compared with those that received RBCs that were younger than 14 days (p = 0.5).This was also true for those who received RBCs that were 28 days or older when compared with those that received RBCs that were younger than 28 days (p = 0.84). CONCLUSION: Procoagulant MP is significantly greater in trauma patients as compared with volunteers, even after adjusting for age and sex. We did not observe any change in the levels of procoagulant MPs after transfusion of stored RBCs. LEVEL OF EVIDENCE: Epidemiologic/prognostic study, level III.
BACKGROUND: We set out to determine the effects of transfusing stored red blood cells (RBCs) on the levels of procoagulant microparticles (MPs) in the blood of traumapatients. METHODS: Blood was drawn and processed to platelet poor plasma for MP analysis for 409 injured patients seen in the trauma bay from February 2011 to January 2013. Blood from 27 noninjured volunteers was also analyzed. Quantification of total procoagulant MP (per microliter plasma) using a direct plasma analysis via flow cytometry was performed. Demographic data, Injury Severity Score (ISS), overall mortality, and units of transfused packed RBCs were collected. Data are presented as median (interquartile range [IQR]). Transfusion groups were assessed using t test or Wilcoxon rank-sum test as appropriate. The α level was set as 0.05 for statistical significance. RESULTS: Median ISS was 12 (IQR, 5-19), 12% were transfused, median age was 48 years (IQR, 29-62 years), 68% were male, and overall mortality was 3%. Median units transfused were 3 (IQR, 2-5). The median number of all procoagulant MP was greater in traumapatients (median 758; IQR, 405-1,627) when compared with our control subjects (median, 232; IQR, 125-372; p < 0.0001). This difference remained significant after adjusting for age and sex (p < 0.0001). In 39 patients who had MP levels measured before transfusion with RBC, the procoagulant MP levels did not change after transfusion (p = 0.07). Patients transfused with RBCs that were 14 days or older did not have increased procoagulant MP levels when compared with those that received RBCs that were younger than 14 days (p = 0.5).This was also true for those who received RBCs that were 28 days or older when compared with those that received RBCs that were younger than 28 days (p = 0.84). CONCLUSION: Procoagulant MP is significantly greater in traumapatients as compared with volunteers, even after adjusting for age and sex. We did not observe any change in the levels of procoagulant MPs after transfusion of stored RBCs. LEVEL OF EVIDENCE: Epidemiologic/prognostic study, level III.
Authors: Albert H M van Straten; Mohamed A Soliman Hamad; André A J van Zundert; Elisabeth J Martens; Joost F ter Woorst; Andre M de Wolf; Volkher Scharnhorst Journal: J Thorac Cardiovasc Surg Date: 2011-01 Impact factor: 5.209
Authors: Lisa Ayers; Malcolm Kohler; Paul Harrison; Ian Sargent; Rebecca Dragovic; Marianne Schaap; Rienk Nieuwland; Susan A Brooks; Berne Ferry Journal: Thromb Res Date: 2011-01-22 Impact factor: 3.944
Authors: Simon D Robinson; Christian Janssen; Eric B Fretz; Brian Berry; Alex J Chase; Anthony Della Siega; Ronald G Carere; Anthony Fung; Gerald Simkus; W Peter Klinke; J David Hilton Journal: Am Heart J Date: 2010-05 Impact factor: 4.749
Authors: Ritha M Belizaire; Priya S Prakash; Jillian R Richter; Bryce R Robinson; Michael J Edwards; Charles C Caldwell; Alex B Lentsch; Timothy A Pritts Journal: J Am Coll Surg Date: 2012-02-17 Impact factor: 6.113
Authors: Myung S Park; Ailing Xue; Grant M Spears; Timothy M Halling; Michael J Ferrara; Melissa M Kuntz; Sabtir K Dhillon; Donald H Jenkins; William S Harmsen; Karla V Ballman; Paul Harrison; John A Heit Journal: J Trauma Acute Care Surg Date: 2015-11 Impact factor: 3.313
Authors: Nena Matijevic; Yao-Wei W Wang; John B Holcomb; Rosemary Kozar; Jessica C Cardenas; Charles E Wade Journal: J Extracell Vesicles Date: 2015-12-17
Authors: Michael J Ferrara; Taleen A MacArthur; Saulius Butenas; Kenneth G Mann; Joseph M Immermann; Grant M Spears; Kent R Bailey; Rosemary A Kozar; Stephanie F Heller; Erica A Loomis; Daniel Stephens; Myung S Park Journal: Res Pract Thromb Haemost Date: 2021-03-08